139512-70-2

Basic information

• Product Name: 4-CHLORO-5-FLUORO-O-PHENYLENEDIAMINE
• Synonyms: TIMTEC-BB SBB003959;1,2-DIAMINO-4-CHLORO-5-FLUOROBENZENE;1-CHLORO-4,5-DIAMINO-2-FLUOROBENZENE;4-CHLORO-1,2-DIAMINO-5-FLUOROBENZENE;4-CHLORO-5-FLUORO-1,2-PHENYLENEDIAMINE;4-CHLORO-5-FLUOROBENZENE-1,2-DIAMINE;4-CHLORO-5-FLUORO-O-PHENYLENEDIAMINE;BUTTPARK 44\03-90
• CAS NO: 139512-70-2
• Molecular Formula: C₆H₆ClFN₂
• Molecular Weight: 160.58
• Product Categories: Fluorine series
• Mol File: 139512-70-2.mol

Chemical Properties

• Melting Point: 110-112 °C
• Boiling Point: 316.2 °C at 760mmHg
• Flash Point: 145 °C
• Appearance: grey to light brown powder
• Density: 1.457 g/cm³
• Vapor Pressure: 0.000417mmHg at 25°C
• Refractive Index: 1.638
• Storage Temp.: 2-8°C(protect from light)
• PKA: 3.16±0.10(Predicted)
• CAS DataBase Reference: 4-CHLORO-5-FLUORO-O-PHENYLENEDIAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CHLORO-5-FLUORO-O-PHENYLENEDIAMINE(139512-70-2)
• EPA Substance Registry System: 4-CHLORO-5-FLUORO-O-PHENYLENEDIAMINE(139512-70-2)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 36/37/38-20/21/22-36-22
• Safety Statements: 36/37/39-26
• RIDADR: 2811
• HazardClass: IRRITANT
• PackingGroup: Ⅲ
• Hazardous Substances Data: 139512-70-2(Hazardous Substances Data)

Usage

Chemical Properties

grey to light brown powder

InChI:InChI=1/C6H6ClFN2/c7-3-1-5(9)6(10)2-4(3)8/h1-2H,9-10H2

Upstream product

• 877-90-7 N-(3-chloro-4-fluorophenyl)acetamide 
• 81962-58-5 N-(3-chloro-4-fluoro-2-nitrophenyl)acetamide 
• 104222-34-6 2-nitro-4-fluoro-5-chloroaniline 
• 367-21-5 3-chloro-4-fluorophenylamine 
• 428871-64-1 4-chloro-5-fluoro-2-nitro-aniline 
• 367-22-6 4-chloro-3-fluoroaniline 

Downstream Products

• 846049-41-0 C₂₆H₂₃BrFN₃ 
• 846049-42-1 C₂₆H₂₂BrClFN₃ 
• 218456-76-9 6-chloro-7-fluoro-2, 3-diphenylquinoxaline 
• 1217303-10-0 2,3,6-trichloro-7-fluoroquinoxaline 

Relevant articles and documents

ANDROGEN RECEPTOR ANTAGONISTS

Compounds that inhibit the androgen receptor, pharmaceutical compositions comprising one or more of the compounds, as well as methods of treating cancer using such compounds are described.

Design, synthesis and anti-HIV activity of novel quinoxaline derivatives

In order to design novel anti-HIV agents, pharmacophore modelling, virtual screening, 3D-QSAR and molecular docking studies were performed. Pharmacophore model was generated using 17 structurally diverse molecules using DISCOtech followed by refinement wi

Indium Mediated Reduction of Nitro and Azide Groups in the Presence of HCl in Aqueous Media

Indium mediated reduction of azide and nitro groups in the presence of HCl (1.5 equiv based on indium) at room temperature in aqueous THF successfully provided the corresponding amine in high to quantitative yields. Under the some reaction conditions, selective reduction of azide and nitro group in the presence of vinyl group could be accomplished.